ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9728
-0.06%
Brent Oil
82.925
-0.24%
Bitcoin
64,231.72
0.36%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Xenetic Biosciences Inc (XBIO)

  7. Xenetic Biosciences Inc (XBIO) Noticias

XBIO

Xenetic Biosciences (XBIO)

Xenetic Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:XBIO
FechaHoraFuenteTítuloSímboloCompañía
12/02/202408:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XBIOXenetic Biosciences Inc
18/12/202316:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XBIOXenetic Biosciences Inc
18/12/202316:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XBIOXenetic Biosciences Inc
13/11/202316:06Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:XBIOXenetic Biosciences Inc
13/11/202316:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:XBIOXenetic Biosciences Inc
09/11/202316:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XBIOXenetic Biosciences Inc
18/09/202311:21Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:XBIOXenetic Biosciences Inc
15/06/202316:21Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:XBIOXenetic Biosciences Inc
02/06/202307:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XBIOXenetic Biosciences Inc
11/05/202315:31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XBIOXenetic Biosciences Inc
22/03/202315:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:XBIOXenetic Biosciences Inc
09/12/202216:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XBIOXenetic Biosciences Inc
10/11/202208:35TipRanksH.C. Wainwright Keeps Their Buy Rating on Xenetic Biosciences (XBIO)NASDAQ:XBIOXenetic Biosciences Inc
21/10/202215:21Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:XBIOXenetic Biosciences Inc
17/10/202216:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:XBIOXenetic Biosciences Inc
03/10/202216:13Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:XBIOXenetic Biosciences Inc
13/05/202205:36TipRanksXenetic Biosciences (XBIO) Gets a Buy Rating from H.C. WainwrightNASDAQ:XBIOXenetic Biosciences Inc
02/05/202205:17TipRanksH.C. Wainwright Maintains Their Buy Rating on Xenetic Biosciences (XBIO)NASDAQ:XBIOXenetic Biosciences Inc
28/04/202215:33Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:XBIOXenetic Biosciences Inc
28/04/202205:25TipRanksH.C. Wainwright Thinks Xenetic Biosciences’ Stock is Going to RecoverNASDAQ:XBIOXenetic Biosciences Inc
30/12/202115:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:XBIOXenetic Biosciences Inc
19/11/202115:55Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:XBIOXenetic Biosciences Inc
25/10/202105:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:XBIOXenetic Biosciences Inc
20/10/202115:31Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:XBIOXenetic Biosciences Inc
15/10/202116:00Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:XBIOXenetic Biosciences Inc
12/10/202116:25Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:XBIOXenetic Biosciences Inc
23/10/201915:25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XBIOXenetic Biosciences Inc
30/09/201916:35Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:XBIOXenetic Biosciences Inc
22/07/201915:20Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)NASDAQ:XBIOXenetic Biosciences Inc
22/07/201915:00Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)NASDAQ:XBIOXenetic Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:XBIO

Su Consulta Reciente

NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
US30
US 30
NYSE
AXP
American Express
NYSE
VZ
Verizon Communications
NASDAQ
AAPL
Apple
NYSE
JPM
JP Morgan Chase
NYSE
CVX
Chevron
NASDAQ
MSFT
Microsoft
CCOM
US500
US 500
NYSE
XOM
Exxon Mobil
NYSE
MRK
Merck
PM
XAUUSD
Gold vs US Dollar
CCOM
SILVER
SILVER
FX
EURUSD
Euro vs US Dollar
NYSE
KO
Coca Cola
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados